Jim Momtazee, a 21-year veteran of KKR, has launched his own investment firm, Patient Square Capital, with an aim of managing large pools of capital with the expertise to meet the "considerable and critical" needs of the healthcare world.
Momtazee helped form KKR's healthcare industry group and subsequently served as head of the Americas Health Care Team for more than a decade. During Momtazee's tenure high-profile investments included Jazz Pharmaceuticals (2004); HCA (2006), a $33 billion transaction which at the time was the largest cash buyout in history; PRA Health Sciences (2013); and . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
